Periprosthetic Infections after Total Hip and Knee Arthroplasty – A Review by Goran Vrgoč et al.
1259
G. Vrgoč et al.: Periprosthetic Joint Infections, Coll. Antropol. 38 (2014) 4: 1259–1264
for further successful treatment. In 11% of cases the cause 
of PJI is not detected despite all diagnostic tools which 
confi rm the existence of infection4. The approach to treat-
ing PJI is complex and it requires a multidisciplinary ap-
proach in order to ensure the most successful treatment 
possible. PJI treatment principles and techniques are nu-
merous depending on the pathogen, patient age, general 
physical condition, functional requirements and bone 
quality. When deciding upon the treatment method, each 
patient should be approached individually.
Therefore, the purpose of this review is to sum up all 
relevant fi ndings on PJI which pose a very important chal-
lenge that accompanies TKA and THA in orthopedics. The 
review will provide a critical opinion on the latest research 
In orthopedics, periprosthetic joint infections (PJI) are 
considered to be very serious and dangerous complications 
of total joint arthroplasty (TJA)1. Because of the usage of 
different material in orthopedics (endoprosthesis, osteo-
synthetic material), regardless of whether aseptic surgical 
principles are observed, the risk of infections is relatively 
high. The major cause of revision surgery after total knee 
arthroplasty (TKA) is infection2. Also, after total hip ar-
throplasty (THA) and the occurrence of infection of pri-
mary THA, revision surgery is the largest and the most 
frequent problem we can enounter3. PJI becomes a long-
lasting medical problem and heavy burden on patient and 
his family. Accurate and early diagnosis of postoperative 
PJI is the key to success. What is most important is to 
differentiate between septic and aseptic loosening of TJA 
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A B S T R A C T
Periprosthetic joint infections (PJI) in orthopedic surgery are considered to be very serious and dangerous complica-
tions of total joint arthroplasty. PJI becomes a long-lasting medical problem and a heavy burden on patient and his 
family. Patients with such a complication are a signifi cant fi nancial burden for the health care system. Recognizing this 
issue, investing in scientifi c research and simultaneously developing technologies in medicine are efforts taken to increase 
successfulness in preventing and treating PJI. Each year the number of total joint arthroplasties increases which entails 
a rise in the number of complications among which infections are the leading ones. Sometimes, in the worst case sce-
narios, infections can endanger patients’ lives. New procedural algorithms and new diagnostic possibilities help us make 
accurate and early diagnoses of postoperative PJI with a great degree of certainty. These diagnostic methods include 
laboratory tests, imaging, histopathology and microbiological analyses. Treatment options depend on many factors which 
include the onset of symptoms, patients’ general physical condition and type of pathogen. The approach to treating PJI is 
complex and it requires a multidisciplinary approach in order to ensure the most successful treatment possible. For ad-
equate and successful treatment we need to take into account antibiotic therapy, one-stage or two-stage revision, Girdle-
stone operation, athrodesis and amputation. In this review we will try to sum up all relevant fi ndings and suggest further 
steps in management of PJI.
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results and suggest further steps that orthopedic surgeons 
could take in their everyday clinical work when dealing 
with PJI.
Epidemiology and Etiology
THA and TKA infections are mainly caused by Staph-
ylococcus aureus and Staphylococcus epidermidis. Accord-
ing to available literature, S. aureus is in 55–58% of 
cases a detected cause of infection which makes it the 
leading pathogen based on frequency. Infections can also 
be caused by other infectious agents such as Streptococcus 
species and gram negative microorganisms, Klebsiella, 
Escherichia coli and Pseudomonas, but to a much lesser 
extent. In a small number of patients whose immune sys-
tem is compromised, there is a possibility of infection 
caused by Candida albicans and Mycobacterium tubercu-
losis5.
In a study which included 69,663 patients who under-
went TKA surgery, 1080 patients had an infection con-
fi rmed within a two year period after TKA surgery, and 
320 patients had an infection confi rmed in the period from 
2 to 10 years6.
At the surface of endoprosthesis bacteria create a bio-
fi lm which gives them protection from the immune system 
and antibiotics. The biofi lm enables the development of 
chronic PJI which is very diffi cult to treat using antibi-
otic therapy. Antibiotics cannot penetrate the biofi lm and 
the bacteria keep differentiating which supports the 
chronic PJI7. Antibiotic action is focused on those bacteria 
which are free and separated from the biofi lm. By limiting 
the dispersion of bacteria and their quantity, we temporar-
ily reduce the clinical symptoms of PJI. As soon as the 
concentration of antibiotics decreases at the site of infec-
tion because therapy is no longer administered, clinical 
symptoms of infection return. This keeps occurring until 
the biofi lm is mechanically removed from the endopros-
thesis and thus the source of infection eradicated, which 
is carried out sugically8.
Diagnosis
Diagnosis always starts with a detailed medical his-
tory and clinical examination which can be of crucial im-
portance for taking further steps and choosing targeted 
examinations in order to make a defi nite diagnosis in the 
shortest possible time.
A patient with a TJA infection most frequently com-
plains about pain localized in the area of an implant. 
Swelling, redness, and hyperthermia can appear which 
speak in favor of the infectious process. Pyrexia, shiver-
ing, chills, loss of mobility in the joint, and unwillingness 
to use the limb are signs which additionally confi rm the 
infection although they are rarely present. Secretion of 
different consistency can sometimes appear in the scar 
area. All these symptoms can indicate a PJI, but they are 
unspecifi c.
Usually the fi rst and the cheapest test which is done 
when there is suspicion of PJI is differential blood count. 
In this fi rst step we want to know whether peripheral 
blood leukocytes, erythrocyte sedimentation rate (ESR) 
and C-reactive protein (CRP) levels are elevated. Leuko-
cytes obtained from peripheral blood are often within the 
normal range so they are not a signifi cant diagnostic test. 
Acute hematogenous infections are an exception where 
values can be elevated due to the presence of bacteraemia5.
We have to be aware that CRP and ESR values can be 
elevated because of some other diseases or conditions what 
diminishes their diagnostic signifi cance. ESR has little 
signifi cance in diagnosing PJI because of its low sensitiv-
ity and specifi city, as opposed to CRP which has a more 
signifi cant role in making a diagnosis. CRP combined 
with interleukine-6 (IL-6) represents a powerful tool in 
diagnosing PJI. In patients with the analysis of postop-
erative PJI markers, the following results were obtained: 
CRP sensitivity 0.95 and specifi city 0.96 as opposed to 
IL-6 which had the same sensitivity value but less specifi c-
ity 0.879. It has been proved that IL-6 values were also 
elevated in patients who had PJI in the last 6 months as 
opposed to patients who did not have PJI what is not the 
case with CRP values which were the same in both groups 
of patients. It has been noticed in the study that a decrease 
of elevated IL-6 values occurs after 6 months from receiv-
ing PJI treatment10.
Exact tests are needed for proving PJI whose results 
will not leave room for doubt. Scientifi c community is in-
tensively working on this and advances are obvious. The 
leukocyte esterase strip test, as a cheap and easy to do 
test, could become a signifi cant contribution in the battle 
against PJI. Testing is carried out so that synovial fl uid 
is taken after TKA and THA and put on strip test. Its 
great advantage is its high accuracy in diagnosing and 
getting results in 60–120 seconds11.
Tissue culture is a diagnostic test which is very helpful 
in detecting PJI. Samples for analysis can be divided into 
superfi cial swab and intraoperative tissue culture. It is 
extremely important to adhere to aseptic protocols when 
taking samples for microbial analysis in order to avoid 
sample contamination. Patients need to be kept without 
antibiotic therapy for minimally 2 weeks before taking 
samples otherwise tests could show falsely negative PJI 
results. Superfi cial swab culture is useful for a faster 
analysis and isolating PJI infectious agents, while the re-
sults of intraoperative tissue culture are considered to be 
the most important data based on which the whole PJI 
treatment is founded on. In a research conducted on the 
same patients, there was overlapping between the results 
of superfi cial swab and intraoperative tissue samples in 
80.3% of cases12. This indicates that both tests need to be 
carried out because each has its advantages and disadvan-
tages.
Joint aspiration should be obligatory in patients with 
THA and TKA if infl ammation markers are elevated or 
in case there is a need for revision surgery. Trampuz et al. 
conducted a research on synovial fl uid in patients with 
TKA where he defi ned the values for diagnosing PJI after 
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joint aspiration was performed. It was concluded in the 
research that the number of leukocytes above 1700/mL and 
neutrophil values above 65% in synovial fl uid are test re-
sults which are highly indicative of PJI. However, in pa-
tients with THA, the values of the same diagnostic test 
were different13. In research conducted by Schinsky et al. 
it has been proved that leukocyte values above 4200/mL 
and neutrophil values over 80% obtained from synovial 
fl uid after THA are values which go in favor of confi rming 
the presence of PJI14.
Sonicate-fl uid culture is a method which is increas-
ingly being used in PJI diagnostics because it has proved 
to be a very useful means for determining a correct diag-
nosis. This is easy to use technique and it does not require 
highly sophisticated facilities to be conducted. A study has 
shown that higher sensitivity in PJI diagnosing using 
sonication-fl uid culture technique (78.5%) was achieved 
as opposed to tissue culture (60.8%) and synovial fl uid 
culture (56.3%) in patients with THA and TKA. We have 
also seen that a preoperative use of antibiotics can lower 
sensitivity of sonication-fl uid and tissue culture15.
In order to provide the best possible treatment, PJI 
have been divided into early, delayed and late based on the 
onset of symptoms after TJA (Table 1.)16.
Tsukayama et al.17 also suggested the classifi cation of 
PJI based on the duration of clinical symptoms of infection 
into: positive intraoperative cultures, early postoperative 
infections, acute hematogenous infections and late chron-
ic infections (Table 2).
Because of different defi nitions and rules for diagnos-
ing PJI, in 2011. a working group was formed with the aim 
to establish a new defi nition for PJI which everyone would 
use for PJI diagnosing. It was concluded that a PJI diag-
nosis can be confi rmed if we have the following:
1. A fi stula which connects the prosthesis with the skin 
surface or,
2. A confi rmed pathogen in 2 or more separate tissue or 
fl uid samples from periprosthetic area or,
3. If 4 out of 6 following conditions have been met:
1. Elevated values of serum ESR and serum CRP,
2. Elevated values of synovial white blood cell count,
3. Elevated values of polymorphonuclear percentage 
synovial fl uid,
4. Purulence in the prosthetic joint,
5. A confi rmed pathogen in one culture of peripros-
thetic tissue or fl uid,
6. > 5 neutrophils per fi eld in 5 high-power fi elds in a 
sample from histologic analysis of periprosthetic tis-
sue at ×400 magnifi cation.
If less than 4 conditions are met, it does not exclude the 
existence of PJI18.
Imaging Studies
The fi rst imaging diagnostic test that we perform when 
there is suspicion of PJI is plain radiographic imaging (two 
projections) of the operated joint. In a large number of 
cases, X-ray images show no irregularities i.e. we do not 
see any changes in bones. Only in a small number of those 
images bone resorption and bone destruction can be seen 
and they are shown as periprosthetic lucency. Peripros-
thetic lucency is characteristic for X-ray images in case of 
chronic infection, and very rare in case of acute infec-
tions5. We have to be aware that radiographic assessment 
is useful for showing endoprosthesis but it is not sensitive 
or specifi c for PJI19. If a PJI is suspected, but X-ray im-
ages are normal, a bone scan using technetium Tc99m 
diphosphonate is done. After injecting, scanning is per-
formed which shows an accumulation of isotopes around 
the prosthesis in case of PJI. This diagnostic technique is 
sensitive, but not specifi c, so it has to be combined with 
some other diagnostic technique in order to make a diag-
nosis. We can also use leukocyte-labeled bone scan meth-
od which is more precise, but also more expensive and it 
TABLE 1




At least 2 positive 
intraoperative cultures
II. Early postoperative 
infections
A. Superfi cial; B. Deep
Less than 1 month after 
implantation
III. Acute hematogenous 
infections
Any time after 
implantation
IV. Late chronic infections  Any time after 1 month 
of implantation
TABLE 2
PJI CLASSIFICATION BASED ON THE DURATION OF
SYMPTOMS
Classifi cation Time of onset Pathogen
Early infections Less than 3 months Most frequently caused by more virulent microorganisms (S. aureus or gram-negative 
bacilli)
Delayed infections From 3 to 24 months They are low grade infections. Caused by less virulent microorganisms 
(coagulase-negative staphylococci or P. acnes)
Late infections After 24 months They are caused by hematogenous spreading
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requires much more time to perform it. Leukocytes need 
to be isolated from the patient’s blood and labeled with 
radioisotopes. After labeled leukocytes are re-injected into 
patient’s body, scanning is done immediately and 24 hours 
after20.
18F-fl uoro-2-deoxyglucose (FDG)-PET can be used for 
detecting PJI because it shows glycolytic cells which form 
part of infection processes. Increased FDG uptake be-
tween prosthesis and bone indicates that there is an infec-
tion. The advantages of this method are its simplicity and 
getting results very quickly which is important for early 
initiation of therapy. In the research carried out by Zhuang 
et al. it has been proved that the sensitivity of this imaging 
method is 90.5% and specifi city 81.1% for PJI in case of 
THA and TKA. Finally, the FDG PET method showed 
better results in detecting PJI in case of THA than in case 
of TKA21.
Computed tomography (CT) enables better bone and 
tissue imaging compared to a plain X-ray. A disadvantage 
of this imaging method is bad image quality because of 
the presence of metal, the material which prostheses are 
made of. Thus, it is rarely used22.
Magnetic resonance imaging (MRI) is an imaging test 
which can provide a lot of data. An advantage is that it 
does not use X-rays for images so exposure is reduced. The 
problem is that metal implants cause disturbances in im-
ages and patients who have metal implants cannot un-




Antibiotic therapy is an integral part of PJI treatment. 
It would be impossible to fi ght infections without it. Al-
though antibiotics are an irreplaceable weapon in PJI 
treatment, one or a combination of antibiotics should be 
smartly chosen. If a wrong choice is made, consequences 
could be signifi cant. Before any use of antibiotics, the sen-
sitivity of the pathogen to the chosen antibiotic should be 
checked. Because of the possibility of resistance of bacteria 
to antibiotics, a combination of two antibiotics should al-
ways be kept in mind as backup in case of resistance4. 
Rifampicin is very successful in treating PJI caused by S. 
aureus. Studies have shown that if it is used in combina-
tion with another antibiotic (levofl oxacin, linezolid), it has 
better results than antibiotic monotherapy. This therapy 
is applied only after infectious agents have been detected 
in the taken samples and have been tested for sensitivity 
to antibiotics23. Rifampicin is avoided as monotherapy in 
PJI treatment caused by S. aureus because of described 
possibility of developing resistance23,24.
Chronic antibiotic suppression is a treatment method 
used in patients who refuse surgical treatment, who are 
in the terminal phase of disease or there is great danger 
of jeopardizing patient’s life with surgical treatment. A 
patient with diagnosed PJI, but without a possibility to 
undergo surgery, needs to use oral antibiotics for life. Goal 
is that the patient tolerates well the chosen oral antibiotic 
and the pathogen is sensible to it. This treatment method 
will not cure infection but only alleviate pain and other 
clinical symptoms. This type of therapy can lead to the 
development of resistance4.
Orthopedic Surgery
Irrigation and debridement include the debridement of 
the affected tissue, replacement of modular components, 
joint irrigation with physiologic fl uid containing antibi-
otic, followed by intravenous antibiotic therapy directed 
towards the pathogen.
In general, acute postoperative and acute hematoge-
nous infections are treated with irrigation and debride-
ment while chronic infections are treated with two-stage 
replacement. One-stage cementless exchange is a possible 
alternative in case of acute postoperative infection after 
THA since it enables better debridement and extraction of 
compromised implants. The period of patient follow-up 
ranged from 27–89 months and the outcome was success-
ful in 70% (19 of 27) of patients since there was no need 
for removing their implant25.
After irrigation and debridement procedures the use of 
outpatient and home parenteral antibiotic therapy 
(OHPAT) for an average of 58 days has been increasing in 
the last few years and now it provides an effi cient method 
for dealing with PJI. Retaining prosthesis thanks to thor-
ough debridement and OHPAT during a longer period of 
time is a good option to avoid revision. A retrospective 
study on 14 patients has demonstrated that this combined 
approach has successful outcomes (70% TKA and 100% 
THA) in patients who were examined up to 6 month after 
treatment. This method has proved to be as effective as 
inpatient treatment; however it has signifi cant advan-
tages such as cost-effectiveness and patients’ content with 
the procedures26.
One stage procedure means that surgery is performed 
in one act, i.e. it includes thorough debridement, irrigation 
and replacement of all components of endoprosthesis. If 
PJI pathogen is known, antibiotic treatment is adminis-
tered according to the antibiogram two to three weeks 
before surgery4.
Two stage procedure includes the removal of endopros-
thesis, thorough irrigation, debridement of the infected 
tissue and installing methyl methacrylate spacer mixed 
with antibiotic in the fi rst stage 20. The endoprosthesis is 
removed and we try to keep as much bone as possible for 
the next stage. We remove the whole cement and take 
samples for microbial analysis. We need to take 6 samples. 
Finally, in TKA we place methyl methacrylate spacer 
mixed with antibiotic, while in THA we do not use the 
spacer. Patient receives intravenous antibiotic therapy for 
6 weeks followed by 6 weeks of break with regular check-
ups for clinical signs of infection and infl ammation mark-
ers. If there are no signs of infection we can proceed with 
the second stage and perform re-implantation. Mahmud 
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et al. research reported on 253 knees with PJI treated 
with two-stage procedures where there was 85% success 
rate in 5 year life span and 78% success rate in 10 year 
life span27. If infection signs are persistent, antibiotic 
treatment should be continued according to the antibio-
gram during 12 weeks for TKA and 24 weeks for THA4.
Girdlestone arthroplasty is an option for treating pa-
tients with THA for whom revision surgery is not an ad-
equate solution for PJI. These are senior patients who 
have lesser functional demands and who would have dif-
fi culties handling more complex surgeries because of their 
weaker general physical condition. The advantage of this 
method is that it alleviates pain and helps cure PJI. Sat-
isfaction rate in patients after this surgical treatment is 
71%. A disadvantage of Girdlestone arthroplasty treat-
ment is the subsequent shortening of extremity and oblig-
atory use of an orthopaedic aid for walking28.
Arthrodesis used to be performed very often in the 
past; however, with the development of surgical tech-
niques and technological progress, it is less and less used 
in orthopaedic surgery for treating PJI. Today, it is used 
in patients with advanced immunodefi ciency and in pa-
tients who have small functional demands4. It has proved 
to be successful in treating infection and alleviating pain 
but its disadvantage is that it restricts patients in their 
everyday activities. It should be kept in mind that it can-
not be used reciprocally on all joints so the solution needs 
to be planned in advance. Arthrodesis can be performed 
with external and internal fi xation. Internal fi xation is 
most commonly done with intramedullary nail which 
gives very good results20.
Amputation is left as the last resort when all other op-
tions have been exhausted. We decide to use this kind of 
surgical treatment when patient’s life is in danger because 
of possible development of sepsis or impossibility of eradi-
cating the source of infections20.
Conclusion
To conclude, a lot remains to be clarifi ed both in PJI 
diagnostics and treatment. Many conclusions and assump-
tions are based on small scale studies and insuffi ciently 
investigative protocols. There are too many opposing stud-
ies where physicians have to decide based on their knowl-
edge, experience and judgment on which protocol seems 
most adequate. A lot of effort is being invested in research-
ing and clarifying the unknowns surrounding PJI. If we 
look into our recent past, it will be clear how much prog-
ress has been made in fi ghting PJI. Day after day we have 
better conditions to fi ght against PJI.
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INFEKCIJE OKO PROTEZE NAKON TOTALNE ARTROPLASTIKE KUKA I KOLJENA
S A Ž E T A K
Infekcije zgloba oko proteze (PJI) u ortopedskoj kirurgiji se smatraju vrlo ozbiljnim i opasnim komplikacijama totalne 
artroplastike. PJI postaje dugotrajan medicinski problem i težak teret za pacijenta i njegovu obitelj. Pacijenti s takvom 
komplikacijom su značajan teret i za zdravstveni sustav. Prepoznajući ovaj problem, investiranje u znanstvena istraživanja 
i istovremeni razvoj tehnologija u medicini predstavljaju napore za povećanjem uspješnosti prevencije i liječenja PJI. 
Svake godine se broj totalnih artroplastika povećava, što utjeće i na porast broja komplikacija, među kojima su vodeće 
infekcije. Ponekad, u najgorem slučaju, infekcije mogu ugroziti život pacijenta. Novi proceduralni algoritmi i nove 
dijagnostičke mogućnosti nam pomažu u postavljanju precizne i rane dijagnoze postoperativne PJI s velikim stupnjem 
sigurnosti. Te dijagnostičke metode uključuju laboratorijske testove, slikovnu dijagnostiku, histopatologiju i mikrobiološke 
analize. Mogućnosti liječenja ovise o brojnim čimbenicima, koji uključuju pojavu simptoma, opće fi zičko stanje pacijenta 
i tip patogena. Pristup liječenju PJI je kompleksan i zahtijeva multidisciplinarni pristup, kako bi se osiguralo najuspješnije 
moguće liječenje. Za prikladno i uspješno liječenje moramo uzeti u obzir antibiotsku terapiju, jednostupanjsku ili dvostu-
panjsku reviziju, operaciju po Girdlestone-u, artrodezu i amputaciju. U ovom pregledu pokušat ćemo prikazati sva rel-
evantna postignuća i predložiti daljnje korake u zbrinjavanju PJI.
